Increasing incidence of severe infectious diseases including COVID-19 and surging demand for antibiotic susceptibility testing are among the key factors driving market revenue growth
According to Emergen Research, the global antimicrobial susceptibility testing/antibiotic sensitivity testing market size was USD 3,226.04 million in 2020 and is expected to reach USD 4,821.04 million in 2028 and register a revenue CAGR of 5.1% during the forecast period, 2021-2028.
Market Dynamics:
Steady revenue growth of the global antimicrobial susceptibility testing/antibiotic sensitivity testing market is primarily driven by increasing occurrence of infectious diseases worldwide, recent outbreak of the novel coronavirus disease, rising public awareness about infectious disease, and increasing volumes of antimicrobial susceptibility testing/antibiotic sensitivity testing procedures. Increasing commercial use of rapid antimicrobial susceptibility testing (AST) systems, increasing research and development activities for more advanced and accurate antimicrobial/antibiotic susceptibility testing equipment or solutions, and rising government investments in the healthcare sector are other major factors projected to boost the global market revenue growth during the forecast period.
Claim Your FREE Sample Copy with Table of content@ https://www.emergenresearch.com/request-sample/381
Antimicrobial susceptibility testing/antibiotic sensitivity testing is performed to detect the level of bacterial or microbial resistance to antibiotics in the human body. Increasing initiatives by healthcare authorities including the EU, WHO, Global Sepsis Alliance (GSA), and Global Health Security Agenda (GHSA) to improve the safety and efficacy AST methods and solutions are expected to further drive the global market growth in the near future. Market revenue growth, however, can be restrained by factors such as high costs of automated antimicrobial susceptibility testing equipment, which come with highly advanced functionalities and features.
COVID-19 Impact Analysis:
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Manual Antimicrobial Susceptibility Testing Products Segment to Account for Largest Revenue Share:
Based on component, the manual antimicrobial susceptibility testing products segment is projected to reach the largest revenue share in the global market over the forecast period. Revenue growth of this segment is majorly driven by factors such as rising cases of infectious diseases, growing susceptibility of children and geriatric people to COVID-19, surging demand for antimicrobial susceptibility testing, and increasing use of manual antimicrobial susceptibility testing products, including MIC strips and susceptibility testing disks and plates.
Clinical Diagnostics Segment Accounted for Largest Revenue Share in 2020:
Among application segments, the clinical diagnostics segment dominated other segments in terms of revenue share in the global antimicrobial susceptibility testing/antibiotic sensitivity testing market in 2020. Growing prevalence of infectious diseases including the coronavirus disease, rising cases of hospital-acquired diseases (HAIs), increasing patient pool, and increasing volumes of clinical diagnostic tests are among the major factors bolstering revenue growth of this segment. Growing need for early disease diagnosis and development of technologically advanced AST solutions are expected to further fuel revenue growth of this segment.
North America Accounted for Largest Revenue Share in 2020:
Among the regional markets, North America accounted for the largest revenue share contribution in the global market in 2020. Rise in geriatric population, increasing cases of infectious diseases such as COVID-19, advances in antimicrobial susceptibility testing solutions, and increasing R&D activities for more advanced and automated AST systems are the key contributors to the North America market revenue growth. Presence of major market players in the region, including Thermo Fisher Scientific, Becton, Dickinson and Company, Bruker Corporation, and Danaher Corporation, is another factor contributing to the regional market growth.
Check Our Prices@ https://www.emergenresearch.com/select-license/381
Major Companies in the Global Market Include:
- Danaher Corporation
- Merck KGaA
- HiMedia Laboratories
- Bruker Corporation
- BioMerieux SA
- Bio-Rad Laboratories
- Precise Automation
- Roche Diagnostics
- Accelerate Diagnostics Inc.
- Becton, Dickinson, and Company
- Liofilchem S.r.l.
- Alifax S.r.l.
- Creative Diagnostics
- Synbiosis
- Bioanalyse
- ELITechGroup
- Mast Group Ltd.
- CONDALAB
- Genefluidics, Inc.
- InvivoGen
- ZHUHAI DL BIOTECH Co., Ltd.
- QuantaMatrix Inc.
For the purpose of this report, Emergen Research has segmented the global antimicrobial susceptibility testing/antibiotic sensitivity testing market based on component, type, method, application, end-use, and region:
Component Outlook (Revenue, USD Million; 2018-2028)
- Manual Antimicrobial Susceptibility Testing Products
- Automated Laboratory Instruments
- Culture & Growth Media
- Consumables
Type Outlook (Revenue, USD Million; 2018-2028)
- Antibacterial Susceptibility/Sensitivity Testing
- Antiparasitic Susceptibility/Sensitivity Testing
- Antifungal Susceptibility/Sensitivity Testing
- Others
Method Outlook (Revenue, USD Million; 2018-2028)
- Disk Diffusion
- E-test Method
- Automated Susceptibility Testing Instruments
- Genotyping Method
- Agar Dilution
- Others
Application Outlook (Revenue, USD Million; 2018-2028)
- Drug Discovery & Development
- Clinical Diagnostics
- Epidemiology
- Others
End-use Outlook (Revenue, USD Million; 2018-2028)
- Hospitals & Clinics
- Pharmaceutical Companies
- Diagnostic Centers
- Research Institutes
- Clinical Research Organizations
Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/antimicrobial-susceptibility-testing-market
By Region (Revenue, USD Million; 2018–2028)
- North America
- S.
- Canada
- Mexico
- Europe
- Germany
- France
- K.
- Italy
- Spain
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- A.E.
- South Africa
- Turkey
- Rest of Middle East & Africa
Take a Look at our Related Reports:
Topical Drug Delivery Market By Product Form (Semi-Solid, Solid Formulations, Transdermal Products, and Liquid Formulations), By Route (Dermal, Ophthalmic, Nasal, Others), By End-Use (Hospitals, Home Healthcare, Clinics, Diagnostic Centers, Burn Center), and By Regions
Medical Smart Textiles Market By Technology (Textile Sensors, Wearable Technology), By Application (Surgery, Bio-Monitoring, Therapy, and Wellness), By End-use (Hospitals and Clinics, Medical Academic and Research Center), and By Region
Operating Room Management Solutions Market By Solution Type (Data management and communication solutions, Operating room supply management solutions, Anesthesia information management solutions, Operating room scheduling solutions, Performance management solutions), By Mode of Deployment (Ob-premises, Cloud-based), By End-Use (Hospitals, Ambulatory surgical centers), and By Region
Patient Registry Software Market By Delivery, By Database, By Registry Type, By Function, By Software Type (Integrated, Standalone), By End-use (Government & Third-Party Administrators, Pharmaceutical Companies, Hospitals, Research Centers, Others), and By Region, Forecast to 2027
Ambulatory EHR Market By Deployment (Cloud-based, On-premises), By Practice Size (Solo Practices, Large Practices, Small-medium-sized Practices), By Application, By End-use (Independent Centers, Hospital-owned Ambulatory Centers, Others), and By Region, Forecasts to 2027
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Facebook | LinkedIn | Twitter | Blogs
Read Full Press Release: https://www.emergenresearch.com/press-release/global-antimicrobial-susceptibility-testing-market